Brainsway (BWAY) Debt to Equity (2018)
Brainsway posted quarterly Debt to Equity of $0.41 for Q4 2018.
Brainsway (BWAY) has 1 years of Debt to Equity data on file, last reported at $0.41 in Q4 2018.
- For the quarter ending Q4 2018, Debt to Equity changed N/A year-over-year to $0.41; the trailing twelve-month figure through Dec 2018 stood at $0.41 (changed N/A YoY), and the FY2018 full-year result was $0.41, changed N/A from the prior year.
- Debt to Equity for Q4 2018 stood at $0.41.
- Across five years, Debt to Equity topped out at $0.41 in Q4 2018 and bottomed at $0.41 in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt/Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.65 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.64 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.57 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.42 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.06 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.95 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.27 |
| 10 | Brainsway | 6.80 Mn | -52.98 Mn | 11.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 0.41 |